Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q29616359)
Watch
English
Hepatocellular carcinoma
scientific article (publication date: 31 March 2012)
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
0 references
title
Hepatocellular carcinoma
(English)
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
author
Josep M. Llovet
object named as
Llovet JM
series ordinal
2
0 references
author name string
Forner A
series ordinal
1
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
Bruix J
series ordinal
3
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
language of work or name
English
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
publication date
31 March 2012
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
published in
The Lancet
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
volume
379
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
issue
9822
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
page(s)
1245-55
1 reference
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
cites work
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coffee drinking and hepatocellular carcinoma: an update.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma in cirrhosis: incidence and risk factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma pathogenesis: from genes to environment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genomics and signaling pathways in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MicroRNA expression, survival, and response to interferon in liver cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pivotal role of mTOR signaling in hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
mTOR and P70 S6 kinase expression in primary liver neoplasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Angiogenesis in liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Principles of cancer screening: lessons from history and study design issues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of screening for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatocellular carcinoma: An update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overdiagnosis in cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Optimization of imaging diagnosis of 1–2cm hepatocellular carcinoma: An analysis of diagnostic performance and resource utilization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current strategy for staging and treatment: the BCLC update and future prospects.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognosis of hepatocellular carcinoma: the BCLC staging classification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and endpoints of clinical trials in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sorafenib in advanced hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The evolving role of radiation therapy in hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transection of the oesophagus for bleeding oesophageal varices
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Resection and liver transplantation for hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Waiting list removal rates among patients with chronic and malignant liver diseases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A model to predict survival in patients with end-stage liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liver transplantation for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Loco-regional treatment of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
NCCN clinical practice guidelines in oncology: hepatobiliary cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961347-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(11)61347-0
2 references
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
30677
OpenCitations bibliographic resource ID
30677
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
30677
PubMed publication ID
22353262
2 references
stated in
PubMed
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22353262
retrieved
30 April 2017
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
30677
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
